These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21388775)

  • 1. SLN biopsy for large and/or multicentric breast cancers: should we worry?
    Cody HS
    Eur J Surg Oncol; 2011 May; 37(5):386-7. PubMed ID: 21388775
    [No Abstract]   [Full Text] [Related]  

  • 2. Axillary recurrence in breast cancer patients with isolated tumor cells in the sentinel lymph node [AJCC N0(i+)].
    Degnim AC; Zakaria S; Boughey JC; Sookhan N; Reynolds C; Donohue JH; Farley DR; Grant CS; Hoskin T
    Ann Surg Oncol; 2010 Oct; 17(10):2685-9. PubMed ID: 20390457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micrometastases in sentinel lymph nodes: few data make for hard decisions.
    Rowan K
    J Natl Cancer Inst; 2009 Oct; 101(20):1374-6. PubMed ID: 19797724
    [No Abstract]   [Full Text] [Related]  

  • 4. Number of lymph nodes removed in sentinel lymph node-negative breast cancer patients is significantly related to patient age and tumor size: a new source of bias in morbidity assessment?
    Port ER; Patil S; Stempel M; Morrow M; Cody HS
    Cancer; 2010 Apr; 116(8):1987-91. PubMed ID: 20151427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to handle positive sentinel nodes?
    Schmidt C
    J Natl Cancer Inst; 2010 Dec; 102(24):1820-1, 1823. PubMed ID: 21139099
    [No Abstract]   [Full Text] [Related]  

  • 6. Lymph node staging surgery and breast cancer: potholes in the fast lane from more to less.
    Moffat FL
    J Surg Oncol; 2005 Feb; 89(2):53-60. PubMed ID: 15660377
    [No Abstract]   [Full Text] [Related]  

  • 7. Recurrence rates in breast cancer patients with false-negative intraoperative evaluation of sentinel lymph nodes.
    Taras AR; Hendrickson NA; Lowe KA; Atwood M; Beatty JD
    Am J Surg; 2010 May; 199(5):625-8. PubMed ID: 20466106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled clinical trial on sentinel node lymph node dissection versus axillary lymph node dissection: a matter of technique or patient selection?
    Carmichael AR
    Ann Surg; 2008 Nov; 248(5):895; author reply 895-6. PubMed ID: 18948821
    [No Abstract]   [Full Text] [Related]  

  • 9. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
    Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
    Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical importance of micrometastasis in sentinel lymph nodes.
    Ozcinar B; Muslumanoglu M; Igci A; Gurdal SO; Yavuz E; Kecer M; Dagoglu T; Ozmen V
    Breast; 2011 Feb; 20(1):31-3. PubMed ID: 20846864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up.
    Kiluk JV; Ly QP; Santillan AA; Meade T; Ramos D; Reintgen DS; Dessureault S; Davis M; Shamehdi C; Cox CE
    Ann Surg Oncol; 2010 Feb; 17(2):552-7. PubMed ID: 19957043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avoidance of axillary lymph node dissection in selected patients with node-positive breast cancer.
    Noguchi M
    Eur J Surg Oncol; 2008 Feb; 34(2):129-34. PubMed ID: 17498911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraoperative cytologic examination of breast sentinel lymph nodes: test utility and patient impact.
    Dabbs DJ; Fung M; Johnson R
    Breast J; 2004; 10(3):190-4. PubMed ID: 15125743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of non-sentinel lymph node metastasis in breast cancer patients.
    Goyal A; Douglas-Jones A; Newcombe RG; Mansel RE;
    Eur J Cancer; 2004 Jul; 40(11):1731-7. PubMed ID: 15251163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management of the axilla in breast cancer: evidences and unresolved issues].
    Fodor J; Polgár C; Péley G; Németh G
    Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal use of sentinel lymph node biopsy versus axillary lymph node dissection in patients with breast carcinoma: a decision analysis.
    Wong SL; Abell TD; Chao C; Edwards MJ; McMasters KM
    Cancer; 2002 Aug; 95(3):478-87. PubMed ID: 12209739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits of locoregional treatment.
    Lawrence GA; Crawford J
    J Clin Oncol; 2003 Dec; 21(24):4660-1; author reply 4661-2. PubMed ID: 14673067
    [No Abstract]   [Full Text] [Related]  

  • 18. Is intra-operative nodal assessment essential in a modern breast practice?
    Benson JR; Wishart GC
    Eur J Surg Oncol; 2010 Dec; 36(12):1162-4. PubMed ID: 20880663
    [No Abstract]   [Full Text] [Related]  

  • 19. Pathological examination of sentinel lymph node in breast cancer: potential problems and possible solutions.
    Hoda SA; Chiu A; Resetkova E; Harigopal M; Hoda RS; Osborne MP
    Microsc Res Tech; 2002 Oct; 59(2):85-91. PubMed ID: 12373718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.